{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:22:47Z","timestamp":1767676967120,"version":"3.37.0"},"reference-count":148,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":11597,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1983,12]]},"DOI":"10.1111\/j.1600-0404.1983.tb01535.x","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T16:13:57Z","timestamp":1233418437000},"page":"49-67","source":"Crossref","is-referenced-by-count":62,"special_numbering":"supplement","title":["Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy"],"prefix":"10.1155","volume":"68","author":[{"given":"Matti","family":"livanainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3565(25)32648-0","article-title":"Barbiturates. Active form and site of action at node of Ranvier sodium channels","volume":"218","author":"Kending","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(25)31775-1","article-title":"Anesthetics: Molecular correlates of voltage and frequency-dependent sodium channel block in nerve","volume":"210","author":"Kendig","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1982.03330010029026","article-title":"Short-acting barbiturate overdosage. Correlation of intoxication score with serum barbiturate concentration","volume":"248","author":"McCarron","year":"1982","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archneur.1979.00500450029003","article-title":"Brain uptake of phenytoin, phenobarbital and diazepam","volume":"36","author":"Ramsay","year":"1979","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-3565(25)27583-8","article-title":"Drug effects on the spontaneous electrical activity of the giant squid axon","volume":"155","author":"Rosenberg","year":"1957","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(25)23279-7","article-title":"Effects of diphenylhydantoin on synaptic transmission in cat spinal cord and stellate ganglion","volume":"120","author":"Esplin","year":"1957","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(79)91074-6","article-title":"Phenytoin and transmitter release at the neuromuscular junction of the frog","volume":"160","author":"Yaari","year":"1979","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB8","first-page":"23","article-title":"Phenobarbital distribution in discrete brain areas of tolerant and nontolerant mice","volume":"18","author":"Becker","year":"1977","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(77)90014-3","article-title":"The influence of phenobarbitone on the distribution of membrane in cortical synapses","volume":"6","author":"Jones","year":"1977","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(78)90771-0","article-title":"An ultrastructural study into the effects of phenobarbitone on synaptic organization","volume":"147","author":"Jones","year":"1978","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0047-6374(80)90012-3","article-title":"The effect of age and phenobarbitone tolerance on pentobarbitone depression of calcium-45 uptake by mouse brain synaptosomes","volume":"14","author":"Jones","year":"1980","journal-title":"Mech Ageing Dev"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-3565(25)32732-1","article-title":"Comparison of ethanol and barbiturate physical dependence","volume":"218","author":"Okamoto","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/clpt.1981.129","article-title":"Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique","volume":"30","author":"Robinson","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB14","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/0006-2952(81)90327-0","article-title":"Acute and chronic effects of barbiturates and ethanol on phospholipid and sulfatide content of rat brain regions","volume":"30","author":"Chweh","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB15","doi-asserted-by":"crossref","unstructured":"15. Savolainen H. Neurotoxicity of industrial chemicals and contaminants: Aspects of mechanisms and effects. Arch Toxicol 1982:Suppl 5: 71-83.","DOI":"10.1007\/978-3-642-68511-8_12"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jnnp.39.10.995","article-title":"Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin","volume":"39","author":"LeQuesne","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1528-1157.1981.tb06157.x","article-title":"Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: A review","volume":"22","author":"So","year":"1981","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(77)90136-3","article-title":"Some aspects of the mechanisms by which industrial solvents produce neurotoxic effects","volume":"18","author":"Savolainen","year":"1977","journal-title":"Chem Biol Interact"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(25)33041-7","article-title":"Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: Evaluation of mephenytoin and its metabolite, Nirvanol","volume":"221","author":"Wells","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB20","first-page":"317","article-title":"Epoxides - is there a human health problem","volume":"37","author":"Manson","year":"1980","journal-title":"Br J Ind Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000115135","article-title":"Distribution of 14C-phenytoin in rat Purkinje cells, cerebellar and cerebral neuronal tissue after a single intraperitoneal injection","volume":"19","author":"Savolainen","year":"1980","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0006-2952(76)90172-6","article-title":"Effects of diphenylhydantoin and phenobarbital on protein metabolism in the rat cerebral cortex","volume":"25","author":"Jones","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3181\/00379727-168-41255","article-title":"Susceptibility of mice to phenytoin-induced cleft palate correlated with inhibition of fetal palatal RNA and protein synthesis","volume":"168","author":"Sonawane","year":"1981","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(75)90445-X","article-title":"Purkinje cell dendritic alterations after transient developmental injury of the external granular layer","volume":"97","author":"Woodward","year":"1975","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.113873","article-title":"Cerebellar plasticity: Modification of Purkinje cell structure by differential rearing in monkeys","volume":"206","author":"Floeter","year":"1979","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB26","first-page":"351","volume-title":"Antiepileptic Drugs","author":"Mattson","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1600-0404.1967.tb05749.x","article-title":"Phenytoin (Dilantin) intoxication","volume":"43","author":"Frantzen","year":"1967","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB28","first-page":"21","article-title":"Behavioural and cognitive disturbances in epileptic children","volume":"73","author":"Trimble","year":"1980","journal-title":"Ir Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0033291700040599","article-title":"Behavioural and psychophysiological studies: Acute effects of diphenylhydantoin in relation to plasma levels","volume":"2","author":"Idestr\u00f6m","year":"1972","journal-title":"Psychol Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.2044-8260.1981.tb00513.x","article-title":"Phenytoin and cognitive functions: Effects on normal volunteers and implications for epilepsy","volume":"20","author":"Thompson","year":"1981","journal-title":"Br J Soc Clin Psychol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneur.1973.00490260022002","article-title":"Folate therapy in epilepsy: A controlled study","volume":"29","author":"Mattson","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.715461","article-title":"Memory impairment in epileptic patients: Selective effects of phenobarbital concentration","volume":"202","author":"MacLeod","year":"1978","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-3476(72)80577-8","article-title":"Maternal barbiturate utilization and neonatal withdrawal symptomatology","volume":"80","author":"Desmond","year":"1972","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB34","first-page":"247","volume-title":"Antiepileptic Drugs","author":"Dam","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1528-1157.1975.tb04741.x","article-title":"Diphenylhydantoin serum levels, toxicity and neuropsychological performance in patients with epilepsy","volume":"16","author":"Dodrill","year":"1975","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jama.1956.02970090046010","article-title":"Hemodialysis, an effective therapy for acute barbiturate poisoning","volume":"161","author":"Berman","year":"1956","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archneur.1960.03840120030004","article-title":"Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin","volume":"2","author":"Buchthal","year":"1960","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jnnp.38.3.225","article-title":"Involuntary movements caused by phenytoin intoxication in epileptic patients","volume":"38","author":"Ahmad","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1528-1157.1977.tb04983.x","article-title":"Phenytoin encephalopathy as probable idiosyncratic reaction: Case report","volume":"18","author":"Ambrosetto","year":"1977","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archneur.1964.00460240074010","article-title":"Diphenylhydantoin metabolism, blood levels and toxicity","volume":"11","author":"Kutt","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.15.8.719","article-title":"Diphenylhydantoin activated seizures","volume":"15","author":"Levy","year":"1965","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmj.2.5912.204","article-title":"Choreoathetosis and encephalopathy induced by phenytoin","volume":"2","author":"McLellan","year":"1974","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1528-1157.1977.tb04980.x","article-title":"Cerebellar atrophy in phenytoin-treated mentally retarded epileptics","volume":"18","author":"Iivanainen","year":"1977","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.27.11.1006","article-title":"Diagnostic and therapeutic revaluation of patients with intractable epilepsy","volume":"27","author":"Porter","year":"1977","journal-title":"Neurology (Minneap)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1212\/WNL.31.3.243","article-title":"Intensive monitoring in refractory epilepsy","volume":"31","author":"Sutula","year":"1981","journal-title":"Neurology (NY)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB46","first-page":"115","article-title":"Ueberlegungen und Beobachtungen zur Pharmakotoxikologie der antiepileptischen Arzneimittel","volume":"45","author":"Dreyer","year":"1974","journal-title":"Nervenarzt"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.26.9.818","article-title":"Cerebellar degeneration following long-term phenytoin therapy","volume":"26","author":"Ghatak","year":"1976","journal-title":"Neurology (Minneap)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410070106","article-title":"Cerebellar degeneration due to chronic phenytoin therapy","volume":"7","author":"McLain","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.31.4_Part_2.405","article-title":"Cerebellar atrophy demonstrated by computed tomography","volume":"31","author":"Koller","year":"1981","journal-title":"Neurology (NY)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB50","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/WNL.32.8.910","article-title":"Cerebellar atrophy in epilepsy and headache: Lack of relationship to phenytoin","volume":"32","author":"Ballenger","year":"1982","journal-title":"Neurology (NY)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB51","first-page":"421","article-title":"Immunofluorescent evidence for a phenytoin receptor in the central nervous system","volume":"30","author":"Hammond","year":"1980","journal-title":"Neurology (NY)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1528-1157.1982.tb05084.x","article-title":"Cerebellar impairment following acute nontoxic administration of phenytoin in rat","volume":"23","author":"Nameli","year":"1982","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00592574","article-title":"Immunohistochemical localization of vitamin D-dependent calcium-binding protein in duodenum, kidney, uterus and cerebellum of chickens","volume":"71","author":"Jande","year":"1981","journal-title":"Histochemistry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archneur.1968.00470310083007","article-title":"Peripheral neuropathy in long-term diphenylhydantoin therapy","volume":"18","author":"Lovelace","year":"1968","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(70)90636-7","article-title":"Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy","volume":"1","author":"Mountain","year":"1970","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB56","first-page":"257","volume-title":"Antiepileptic Drugs","author":"Pisciotta","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB57","first-page":"614","article-title":"Aplastic anemia secondary to anticonvulsants","volume":"104","author":"Robins","year":"1962","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB58","first-page":"495","article-title":"Incidence of anticonvulsant osteomalacia and effect of vitamin D: Controlled therapeutic trial","volume":"4","author":"Christiansen","year":"1974","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.4.5727.73","article-title":"Disturbance of calcium metabolism by anticonvulsant drugs","volume":"4","author":"Richens","year":"1970","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB60","first-page":"64","article-title":"Effects of long-term anticonvulsant therapy on calcium and vitamin D metabolism","volume":"67","author":"Stamp","year":"1974","journal-title":"Proc R Soc Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003495-197612030-00003","article-title":"Bone complications of anticonvulsants","volume":"12","author":"Hahn","year":"1976","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/adc.52.3.239","article-title":"Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs","volume":"52","author":"Friis","year":"1977","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB63","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.0954-6820.1976.tb06747.x","article-title":"Anticonvulsant osteomalacia determined by quantitative analysis of bone changes","volume":"199","author":"Mosekilde","year":"1976","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.410050411","article-title":"Effect of phenytoin on bone and vitamin D metabolism","volume":"5","author":"Bell","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.0954-6820.1977.tb15704.x","article-title":"Effect of long-term vitamin D-2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia","volume":"207","author":"Mosekilde","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1600-0404.1974.tb02808.x","article-title":"Initial and maintenance doses of vitamin D-2 in the treatment of anticonvulsant osteomalacia","volume":"50","author":"Christiansen","year":"1974","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB67","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.2.6048.1340","article-title":"British Medical Journal, Editorial: Anticonvulsant osteomalacia","volume":"2","year":"1976","unstructured":"67. British Medical Journal, Editorial: Anticonvulsant osteomalacia. Br Med J 1976:2: 1340-1341.","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/WNL.29.2.175","article-title":"Phenytoin hepatotoxicity: A case report and review","volume":"2","author":"Parker","year":"1979","journal-title":"Neurology (Minneap)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01072286","article-title":"Cholestatic liver disease associated with diphenylhydantoin therapy: Possible pathogenetic importance of altered bile salt metabolism","volume":"22","author":"Cambell","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-83-4-522","article-title":"Severe sensitivity to diphenylhydantoin with circulating antibodies to the drug","volume":"83","author":"Kleckner","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1445-5994.1975.tb03863.x","article-title":"Diphenylhydantoin sensitivity: A syndrome resembling infectious mononucleosis with a morbilliform rash and cholestatic hepatitis","volume":"5","author":"Weedon","year":"1975","journal-title":"Aust N Z J Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.1965.03080150101033","article-title":"Sodium diphenylhydantoin reaction with evidence of circulating antibodies","volume":"192","author":"Robinson","year":"1965","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB73","first-page":"318","article-title":"Diphenylhydantoin fatal hepatic necrosis","volume":"7","author":"Chien","year":"1970","journal-title":"Ala J Med Sci"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB74","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI105831","article-title":"Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital","volume":"47","author":"Oppenheimer","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1978.tb01493.x","article-title":"Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs","volume":"8","author":"Liewendahl","year":"1978","journal-title":"Clin Endocrinol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB76","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/bmj.1.6127.1581","article-title":"Anticonvulsants and thyroid function","volume":"1","author":"Yeo","year":"1978","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB77","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2125.1976.tb00355.x","article-title":"Effect of phenytoin therapy on thyroid function","volume":"3","author":"Finucane","year":"1976","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0026-0495(74)90079-1","article-title":"Endocrine manifestations of diphenylhydantoin therapy","volume":"23","author":"Gharib","year":"1974","journal-title":"Metabolism"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB79","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cpt1977226912","article-title":"Effectiveness of prednisolone during phenytoin therapy","volume":"22","author":"Petereit","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3476(76)80745-7","article-title":"The adverse effect of anticonvulsant therapy on renal allograft survival","volume":"55","author":"Wassner","year":"1976","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/bmj.2.6092.934-a","article-title":"Induction of sex hormone binding globulin by phenytoin","volume":"2","author":"Victor","year":"1977","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB82","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/jnnp.41.10.913","article-title":"Effect of anticonvulsants on plasma testosterone and sex hormone binding globulin levels","volume":"41","author":"Barragry","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB83","first-page":"101A","article-title":"Effects of Dilantin on FSH and spermatogenesis","volume":"24","author":"Stewart-Bentley","year":"1976","journal-title":"Clin Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB84","first-page":"190","volume-title":"Epileptology","author":"Christiansen","year":"1977"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.pa.09.040169.000321","article-title":"Drugs and enzyme induction","volume":"9","author":"Kuntzman","year":"1969","journal-title":"Annu Rev Pharmacol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB86","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(74)90593-5","article-title":"Anti-epileptic drugs and failure of oral contraceptives","volume":"1","author":"Janz","year":"1974","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB87","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1542\/peds.48.3.372","article-title":"Phenobarbitone prophylaxis for neonatal hyperbilirubinemia","volume":"48","author":"Yeung","year":"1971","journal-title":"Prediatrics"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3476(73)80497-4","article-title":"Effect of phenobarbital on hyperlipemia in patients with intrahepatic and extrahepatic cholestasis","volume":"83","author":"Linarelli","year":"1973","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB89","first-page":"814","article-title":"Effect of phenobarbital and heroin metabolism in the rat","volume":"34","author":"Cramer","year":"1975","journal-title":"Fed Proc"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB90","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.1965.tb12256.x","article-title":"Hepatic porphyria and drug-induced or chemical porphyria","volume":"123","author":"Granick","year":"1965","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bmj.2.6130.99","article-title":"Increase of serum high-density lipoprotein in phenytoin users","volume":"2","author":"Nikkil\u00e4","year":"1978","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/newbio233181a0","article-title":"Suppression of immunity by phenobarbital","volume":"233","author":"Park","year":"1971","journal-title":"Nature (New Biol)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB93","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archinte.1972.00320060136020","article-title":"Diphenylhydantoin effects on hyman lymphocytes in vitro and in vivo","volume":"129","author":"MacKinney","year":"1972","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-3083.1975.tb02641.x","article-title":"Effects of antiepileptic drugs on serum and salivary IgA","volume":"4","author":"Aarli","year":"1975","journal-title":"Scand J Immunol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1528-1157.1976.tb03407.x","article-title":"Phenytoin-induced depression of salivary IgA and gingival hyperplasia","volume":"77","author":"Aarli","year":"1976","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00016487609120879","article-title":"Immunodeficiency syndromes with otorhinolaryngological manifestations","volume":"82","author":"Berdal","year":"1976","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1981.tb00746.x","article-title":"Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients","volume":"63","author":"Gilhus","year":"1981","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB98","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0404.1976.tb04374.x","article-title":"Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy","volume":"54","author":"Aarli","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB99","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jnnp.41.7.593","article-title":"Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy","volume":"47","author":"Fontana","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jnnp.41.4.307","article-title":"Metabolism of immunoglobulin A. lymphocyte function, and histocompatibility antigens in patients on anticonvulsants","volume":"41","author":"Shakir","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB101","first-page":"273","article-title":"Depression of immune competence by phenytoin and carbamazepine","volume":"20","author":"Sorrell","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB102","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(76)90512-2","article-title":"Immunological side-effects of anticonvulsants","volume":"7","author":"Massimo","year":"1976","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB103","first-page":"1","article-title":"A comparative enzyme histochemical study of hydantin induced hyperplastic and normal human gingiva","volume":"73","author":"Larmas","year":"1977","journal-title":"Proc Finn Dent Soc"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-69-3-557","article-title":"Hydantoin-induced pseudo-pseudolymphoma","volume":"69","author":"Gams","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-9343(75)90507-0","article-title":"Diphenylhydantoin-induced serum sickness with fibrin-platel\u00e9t thrombi in lymph node microvasculature","volume":"58","author":"Zidar","year":"1975","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB106","first-page":"121","article-title":"Hypersensitivity angiitis from diphenylhydantoin","volume":"59","author":"Watanabe","year":"1964","journal-title":"Acta Derm (Kyoto)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB107","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-83-2-227","article-title":"Dilantin-induced disseminated intravascular coagulation with purpura fulminans. A case report","volume":"83","author":"Targan","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB108","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1001\/jama.1976.03270250041024","article-title":"Reversible renal failure and myositis caused by phenytoin hypersensitivity","volume":"236","author":"Michael","year":"1976","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0954-6820.1977.tb15657.x","article-title":"Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy","volume":"201","author":"Andersen","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(65)80189-5","article-title":"Diphenylhydantoin induced hypersensitivity reaction","volume":"66","author":"Holland","year":"1965","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB111","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)31126-2","article-title":"Morphologic effect of hydantoin drugs on mitosis and microtubules of cultured human lymphocytes","volume":"204","author":"MacKinney","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)31125-0","article-title":"Hydantoin drugs inhibit polymerization of pure microtubular protein","volume":"204","author":"MacKinney","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB113","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM197311152892001","article-title":"Diphenylhydantoin and selected congenital malformations","volume":"289","author":"Monson","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB114","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(76)91403-3","article-title":"Anticonvulsants and parental epilepsy in the development of birth defects","volume":"1","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB115","first-page":"363","article-title":"Congenital malformation among infants of epileptic mothers treated during pregnancy - the report of a collaborative study group in Japan","volume":"35","author":"Nakane","year":"1979","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB116","first-page":"289","volume-title":"Epilepsy, Pregnancy and the Child","author":"Bjerkedal","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB117","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.63.2.331","article-title":"Anticonvulsants and pregnancy","volume":"63","author":"American Academy of Pediatrics. Committee on Drugs","year":"1979","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB118","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3476(76)80414-3","article-title":"Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome","volume":"89","author":"Hanson","year":"1976","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB119","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0022-3476(77)80422-8","article-title":"Are hydantoins (phenytoins) human teratogens","volume":"90","author":"Hanson","year":"1977","journal-title":"J Pediatr"},{"issue":"337","key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB120","first-page":"1337","article-title":"Teratogenicity of anticonvulsive medications","volume":"131","author":"Smith","year":"1977","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB121","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1651-2227.1976.tb04941.x","article-title":"Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero","volume":"65","author":"Seip","year":"1976","journal-title":"Acta Paediatr Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB122","first-page":"347","volume-title":"Intensive care in the newborn","author":"Vert","year":"1979"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1651-2227.1982.tb09418.x","article-title":"Teratogenic and pharmacokinetic studies of primidone during pregnangcy and in the offspring of epileptic woman","volume":"71","author":"Rating","year":"1982","journal-title":"Acta Paediatr Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB124","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM197805112981906","article-title":"The fetal alcohol syndrome","volume":"298","author":"Clarren","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7455686","article-title":"Phenytoin-induced teratogenesis: A mouse mode","volume":"211","author":"Finnell","year":"1981","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB126","first-page":"28","article-title":"Chromocomal effects of diphenylhydantoins","volume":"17","author":"Munitz","year":"1969","journal-title":"Clin Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB127","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0027-5107(77)90014-8","article-title":"Long-term use of phenytoin effects on bone marrow chromosomes in man","volume":"43","author":"Knuutila","year":"1977","journal-title":"Mutat Res"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archpedi.1974.02110240031002","article-title":"Infants exposed in utero to antiepileptic drugs","volume":"127","author":"Hill","year":"1974","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB129","first-page":"240","volume-title":"Epilepsie 1978. Epilepsiebedingte Hirnsch\u00e4den - Psychogene Anf\u00e4lle - Audiovisuelle Anfallsanalyse","author":"Rating","year":"1979"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB130","first-page":"425","volume-title":"Epilepsy, Pregnancy, and the Child","author":"J\u00e4ger-Roman","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB131","first-page":"197","volume-title":"Epilepsy, Pregnancy, and the Child","author":"Ogawa","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB132","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(81)90354-8","article-title":"Fetal head growth retardation associated with maternal antiepileptic drugs","volume":"2","author":"Hiilesmaa","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB133","first-page":"175","volume-title":"Epilepsy, Pregnancy, and the Child","author":"Bjerkedal","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB134","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bmj.2.5864.442","article-title":"Epilepsy and pregnancy: A report from the Oxford Record Linkage Study","volume":"2","author":"Fedrick","year":"1973","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB135","first-page":"461","volume-title":"Advances in Epileptology, XIIth Epilepsy International Symposium","author":"Round","year":"1981"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB136","first-page":"397","volume-title":"Epilepsy, Pregnancy, and the Child","author":"Granstr\u00f6m","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB137","first-page":"449","article-title":"Anticonvulsant medication","volume":"133","author":"Hill","year":"1979","journal-title":"Am Dis Child"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1976.tb04789.x","article-title":"Phenytoin and phenobarbitone plasma clearance during pregnancy","volume":"54","author":"Mygind","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB139","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1212\/WNL.27.2.128","article-title":"Plasma anticonvulsant concentrations during pregnancy","volume":"27","author":"Lander","year":"1977","journal-title":"Neurology (Minneap)"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003088-197904010-00005","article-title":"Antiepileptic drugs: Metabolism in pregnancy","volume":"4","author":"Dam","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB141","unstructured":"141. Bardy A H . Epilepsy and pregnancy. A prospective study of 154 pregnancies of epileptic women. ISBN 951-99412-5-8 Thesis, University of Helsinki, 1982: 1-74."},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB142","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(81)90029-5","article-title":"Phenytoin binding in pregnancy","volume":"1","author":"Ruprah","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB143","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(80)90262-7","article-title":"Decreased serum protein binding of phenytoin in late pregnancy","volume":"2","author":"Ruprah","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB144","first-page":"403","volume-title":"Epilepsy, Pregnancy, and the Child","author":"Granstr\u00f6m","year":"1982"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9394(77)90693-6","article-title":"Is there a \u201cfetal hydantoin syndrome\u201d","volume":"84","author":"Apt","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB146","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3476(77)80421-6","article-title":"Are hydantoins (phenytoins) human teratogens","volume":"90","author":"Shapiro","year":"1977","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB147","first-page":"37","volume-title":"Antiepileptic Drug Therapy in Pediatrics","author":"Bossi","year":"1983"},{"key":"10.1111\/j.1600-0404.1983.tb01535.x-BIB148","first-page":"65","volume-title":"Antiepileptic Drug Therapy in Pediatrics","author":"Iivanainen","year":"1983"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1983.tb01535.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1983.tb01535.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:05:11Z","timestamp":1738922711000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1983.tb01535.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":148,"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1983.tb01535.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"type":"print","value":"0001-6314"},{"type":"electronic","value":"1600-0404"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}